Takashi Owa

	Marysville Arlington Boston Ibaraki Woodcliff lake

	Eisai President Oncology Epizyme FDA Chief Innovation Officer Vice President Chief Medicine Creation Eisai Product Creation

Images of Takashi Owa

(0 from 0 )

News

(1 - 4 from 16

–show all

)

ESALY Company Profile & Executives - Eisai Co. Ltd. ADR - Wall Street...

www.wsj.com

ESALY - key executives, insider trading, ownership, revenue and average growth rates. Detailed company description & address for Eisai Co. Ltd. ADR.

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of...

www.news-medical.net

... offering this new treatment option to patients with progressive, RAI-refractory DTC," said Takashi Owa, Ph.D., Chief Innovation Officer at Eisai.

Eisai and PIQUR Sign Landmark Collaboration Agreement to Investigate...

www.prnewswire.co.uk

HATFIELD, England and BASEL, Switzerland, February 17, PR Newswire UK/ -- Eisai and PIQUR Sign Landmark Collaboration Agreement to Investigate...

Eisai and PIQUR sign landmark collaboration agreement...

www.startupticker.ch

... may provide new treatment options for patients with TNBC,” said Dr Takashi Owa, Chief Innovation Officer, Vice President Eisai Co., Ltd.

Telephone & Addresses

(1 - 4 from 11

–show all

)

Takashi Owa, Arlington, US, Park Ave, Apt 203

View Takashi's social profiles and photos on Facebook, MySpace, and +40 Networks.

Takashi Owa, Boston, US, Joslin Pl, Unit 439

View Takashi's social profiles and photos on Facebook, MySpace, and +40 Networks.

Takashi P Owa, 44, Marysville, US, 108th St NE

View Takashi's social profiles and photos on Facebook, MySpace, and +40 Networks.

Takashi P Owa, 44, Marysville, US, 96th St NE

View Takashi's social profiles and photos on Facebook, MySpace, and +40 Networks.

Physicians & MDs

PPT - The Lancet

www.thelancet.com

... PhD, Eric Hedrick, MD, Heike Keilhack, PhD, Blythe Thomson, MD, Takashi Owa, PhD, Robert A Copeland, PhD, Peter T C Ho, MD, Vincent Ribrag, MD.

Network Profiles

Facebook: Takashi Owa | Facebook

Facebook: Takashi Owa - Facebook

Interests

(1 - 4 from 6

–show all

)

Eisai (ESALY) Q Results - Earnings Call Transcript | Seeking...

seekingalpha.com

Takashi Owa – Vice President, Chief Innovation Officer, Eisai Product Creation Systems. Hideshi Honda – Representative Corporate Officer ...

Takashi Owa - Patents

www.freshpatents.com

Takashi Owa patents. Recent bibliographic sampling of Takashi Owa patents listed/published in the public domain by the USPTO (USPTO Patent Application # ...

Eisai and Johns Hopkins Extend Drug Discovery Collaboration with New...

www.prnewswire.com

"We are excited to continue our work with Professor Slusher and her drug discovery team at Johns Hopkins," said Dr. Takashi Owa, Chief ...

Eisai's (ESALF) Q Results - Earnings Call Transcript | Seeking...

seekingalpha.com

Teiji Kimura - Chief Discovery Officer, Neurology Business Group. Takashi Owa - Chief Medicine Creation Officer, Oncology Business Group.

Business Profiles

patentbuddy: Takashi Owa

EISAI R&D MANAGEMENT CO., LTD., Ibaraki, JP

Publications

Marine Drugs | Free Full-Text | Microarray-Based Transcriptional...

www.mdpi.com

Kornvika Charupant 1, Khanit Suwanborirux 1,* , Naomi Daikuhara 2, Masashi Yokoya 2, Rie Ushijima-Sugano 3, Takatoshi Kawai 3, Takashi Owa 3,* and ...

Oalib search

www.oalib.com

Kornvika Charupant,Khanit Suwanborirux,Naomi Daikuhara,Masashi Yokoya,Rie Ushijima-Sugano,Takatoshi Kawai,Takashi Owa,Naoki ...

Reports & Statements

Splicing factor SF3b as a target of the antitumor natural product...

www.nature.com

Letter

Selective degradation of splicing factor CAPERα by anticancer...

www.nature.com

Article

Miscellaneous

(1 - 20 from 38

–show all

)

Takashi Owa | LinkedIn

www.linkedin.com

View Takashi Owa's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Takashi Owa discover inside ...

- ppt download

slideplayer.com

Antitumor activity- and gene expression-based profiling of ecteinascidin Et 743 and phthalascidin Pt 650 Eduardo J Martinez, E.J Corey, Takashi Owa Chemistry ...

Eisai and PIQUR Sign Landmark Collaboration Agreement to ...

finance.yahoo.com

... PQR309 may provide new treatment options for patients with TNBC," said Dr Takashi Owa, Chief Innovation Officer, Vice President Eisai Co., ...

New Data from Investigational Study of LENVIMA® (lenvatinib) and ...

finance.yahoo.com

... potential of this combination,” said Dr. Takashi Owa, Vice President and Chief Medicine Creation Officer, Oncology Business Group at Eisai.

Quantitative chemical proteomics for identifying candidate drug...

acs.confex.com

Takashi Owa, Eisai Co., Ltd., Tsukuba, Ibaraki, Japan. Cell-based phenotypic screening of diverse compound collections is an important ...

Takashi Owa - Executive of Eisai | ESALF

cdn.macroaxis.netdna-cdn.com

Mr. Takashi Owa was serving as Executive Officer and Chief Innovation Officer in Eisai Co. Ltd. since June He joined the Company in April He used ...

Takashi Owa - Corporate Insider | ESALY.PK

www.macroaxis.com

Eisai Co Ltd executive: Takashi Owa. Insider profile, background and performance of Takashi Owa and Eisai Co and other executives: Eisai Co | ESALY.PK.

Takashi Owa Archives - Pf Media

pf-media.co.uk

Tag: Takashi Owa. Pharma News · Carcinoma treatment LENVIMA® + KEYTRUDA® supported by FDA · Hannah Alderton - July 31, SUBSCRIBE ...

Takashi Owa | Bay City Capital | Email President Oncology Product...

www.joesdata.com

Email, phone number & executive profile for Takashi Owa, President Oncology Product Creation Unit of Bay City Capital at San Francisco, CA

Takashi Owa | Eisai Co Ltd | Japan

biography.omicsonline.org

Takashi Owa is the Chief Discovery Officer, Oncology Business Group..

ESALY | Eisai Co. Ltd. ADR Individual Insiders | MarketWatch

www.marketwatch.com

ESALY Stock Quote, and financial news from the leading provider and award-winning MarketWatch.com.

www.infona.pl

Bioorganic & Medicinal Chemistry Letters 14 , 1 ,

5024 Wilmington Ave Everett Wa Address Search Results

www.fastpeoplesearch.com

Used to live: Everett, WA, Arlington, WA, Marysville, WA, Las Vegas, NV. AKA: Paul T Owa , Takashi Paul Owa , Takashipaul Owa , Takashi Owa , Paul Owa.

Anticancer and Antiviral Sulfonamides | Bentham Science

www.eurekaselect.com

Author(s): Andrea Scozzafava, Takashi Owa, Antonio Mastrolorenzo, Claudiu T. Supuran. Universita degli Studi di Firenze, Dipartimento di Chimica, Laboratorio ...

Client Portal - Overview

nomuraiconf.dealogic.com

lMr. Takashi Owa: Chief Innovation Officer, Eisai Product Creation Systems, Vice President, Eisai. *** Healthcare Session confirmed in the afternoon of Dec 5th.

Antitumor activity- and gene expression-based profiling of...

www.infona.pl

Antitumor activity- and gene expression-based profiling of ecteinascidin Et 743 and phthalascidin Pt Autorzy. Eduardo J. Martinez E.J. Corey Takashi Owa.

Eisai Newsroom - Press Releases

eisai.mediaroom.com

Eisai Newsroom

Eisai and Merck Announce China Approval of Lenvima for Treatment of...

www.cafepharma.com

Lenvima is the first new systemic therapy approved for the first-line treatment of unresectable HCC in China in ten years In China, there are approximately...

Defined Health Announces Cancer Stem Cells Panel at the 24th Annual...

www.biospace.com

Defined Health Announces Cancer Stem Cells Panel at the 24th Annual Cancer Progress Conference on March 5th-6th, read this article along with other...

Xconomy: Epizyme Buys Back Control of Cancer Drug From Eisai For up...

xconomy.com

Throughout its history, Epizyme has always kept an eye on staying independent. When it was accumulating partnerships for its epigenetics research a few

Related search requests for Takashi Owa

People
Forename "Takashi" (2421)
Name "Owa" (39)

sorted by relevance / date

Advanced Search

Save as document

Search name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Takashi Owa Free People Check

Images of Takashi Owa

Physicians & MDs

Network Profiles

Business Profiles

Related Documents

Publications

Reports & Statements